Rosalyn Hithersay
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Exploring semantic verbal fluency patterns and their relationship to age and Alzheimer's disease in adults with Down syndrome.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: October 18, 2022
Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain.
Journal: Molecular psychiatry
Published: July 17, 2021
The Association between Physical Activity and CAMDEX-DS Changes Prior to the Onset of Alzheimer's Disease in Down Syndrome.
Journal: Journal of clinical medicine
Published: March 29, 2021
Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome.
Journal: JAMA network open
Published: September 28, 2020
Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study.
Journal: The Lancet. Neurology
Published: July 18, 2020
Optimal age and outcome measures for Alzheimer's disease prevention trials in people with Down syndrome.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: June 08, 2020
Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain.
Journal: Molecular psychiatry
Published: January 29, 2020
Reply to "Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management".
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: August 28, 2019
Health comorbidities and cognitive abilities across the lifespan in Down syndrome.
Journal: Journal of neurodevelopmental disorders
Published: December 03, 2018
Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years.
Journal: JAMA neurology
Published: November 20, 2018
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease.
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease.
Journal: Alzheimer's research & therapy
Published: August 28, 2018
Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome.
Journal: Frontiers in psychiatry
Published: August 26, 2018
Last Updated: 09/26/2026